摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-methylphenyl)-thiomorpholine 1,1-dioxide | 82222-70-6

中文名称
——
中文别名
——
英文名称
4-(2-methylphenyl)-thiomorpholine 1,1-dioxide
英文别名
4-o-tolyl-thiomorpholine-1,1-dioxide;4-o-Tolyl-thiomorpholin-1,1-dioxid;4-(2-Methylphenyl)-1,4-thiazinane 1,1-dioxide
4-(2-methylphenyl)-thiomorpholine 1,1-dioxide化学式
CAS
82222-70-6
化学式
C11H15NO2S
mdl
——
分子量
225.312
InChiKey
NAVWOXFIQWLBSM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    141.0-143.5 °C
  • 沸点:
    433.2±45.0 °C(predicted)
  • 密度:
    1.220±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    45.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    二乙烯基砜甲基硝基苯indium氯化铵溶剂黄146 作用下, 以 甲醇 为溶剂, 反应 24.0h, 以37%的产率得到4-(2-methylphenyl)-thiomorpholine 1,1-dioxide
    参考文献:
    名称:
    One-Pot Aryl-1,4-thiomorpholine 1,1-Dioxide Synthesis via Double 1,4-Addition of in situ Reduced Nitroarenes to Divinyl Sulfones
    摘要:
    One-pot reduction-triggered double aza-Michael type 1,4-addition reactions of various nitroarenes to divinyl sulfones were investigated. In the presence of indium/AcOH in MeOH or in sat. aq NH(4)Cl/MeOH, nitroarenes and divinyl sulfones were cyclized to give 1,4-thiomorpholine 1,1-dioxides.
    DOI:
    10.3987/com-09-11858
点击查看最新优质反应信息

文献信息

  • Pyrrolidine derivative or salt thereof
    申请人:Hachiya Shunichiro
    公开号:US20090062366A1
    公开(公告)日:2009-03-05
    [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).
    [问题] 提供一种可用于治疗钙敏感受体(CaSR)相关疾病,特别是甲状旁腺功能亢进症的化合物。 [解决方法] 发现了一种新型吡咯烷衍生物,其特征在于具有氨甲基基团,该基团被芳基烷基或类似物取代,或其盐,具有出色的CaSR激动调节活性,并且具有出色的选择性与CYP2D6抑制活性,可能导致药物相互作用。基于以上发现,这些新型吡咯烷衍生物可用作治疗CaSR相关疾病(甲状旁腺功能亢进症,肾性骨营养不良,高钙血症等)的治疗剂。
  • AZOLECARBOXAMIDE DERIVATIVE
    申请人:Sugasawa Keizo
    公开号:US20090286766A1
    公开(公告)日:2009-11-19
    Provided is an agent for treating or preventing urinary frequency, urinary urgency and urinary, incontinence which are associated with overactive bladder, a lower urinary tract disease such as interstitial cystitis and chronic prostatitis accompanied by lower urinary tract pain, and various diseases accompanied by pain. A novel azolecarboxamide derivative in which an azole ring such as thioazole or oxazole is bonded to a benzene ring, pyridine ring or pyrimidine ring through carboxamide was confirmed to have a potent trkA receptor-inhibitory activity and found to be an agent for treating or preventing lower urinary tract disease and various diseases accompanied by pain, which is excellent in efficacy and safety, and thus the present invention was accomplished.
    提供了一种用于治疗或预防与过度活跃膀胱、下泌尿道疾病(如间质性膀胱炎和慢性前列腺炎伴随下泌尿道疼痛)以及伴随疼痛的各种疾病相关的尿频、尿急和尿失禁的药剂。一种新型的唑烷羧酰胺衍生物,其中唑环(如硫唑环或噁唑环)通过羧酰胺键连接到苯环、吡啶环或嘧啶环上,被证实具有强效的trkA受体抑制活性,并被发现是一种用于治疗或预防下泌尿道疾病和伴随疼痛的各种疾病的药剂,其疗效和安全性优异,因此本发明得以完成。
  • Reagentless Chemistry “On-Water”: An Atom-Efficient and “Green” Route to Cyclic and Acyclic β-Amino Sulfones via aza-Michael Addition Using Microwave Irradiation
    作者:Soumik Saha、Amrita Chatterjee、Mainak Banerjee
    DOI:10.1021/acs.joc.3c01855
    日期:2023.11.3
    was developed for facile access to cyclic and acyclic β-amino sulfones “on-water” using a microwave. A variety of aromatic and aliphatic amines undergo double aza-Michael addition on the surface of the water with water-insoluble divinyl sulfones upon microwave irradiation at 150 °C for 10 min to mostly afford solid cyclic β-amino sulfones as easily separable products in excellent yields by simple filtration
    开发了一种无试剂、无催化剂且可持续的方法,可以使用微波轻松地“在水上”获得环状和无环 β-氨基砜。在 150 °C 微波照射 10 分钟后,各种芳香族和脂肪族胺与水不溶性二乙烯基砜在水表面进行双氮杂迈克尔加成,大部分得到固体环状 β-氨基砜,作为易于分离的产品,具有优异的性能。通过简单过滤即可获得产量,避免任何后处理步骤。因此,基材的所有原子都反映在产品中,使其成为 100% 原子效率的方法。富电子胺和缺电子胺都很好地参与了反应,并且观察到良好的官能团耐受性。竞争性实验预期揭示了富电子胺更快的反应动力学。通过以类似的方式使苯基/乙基乙烯基砜与各种胺相互作用,该方法扩展到无环 β-氨基砜。正如预期,该方法提供了非常低的环境因素(在 0.05-0.5 范围内)和较高的 Ecoscale 得分(高达 94)。为了实现可持续发展,这种无试剂、无金属、无有机溶剂、具有成本效益的方案无疑是现有 β-氨基砜方法的可行替代方案。
  • PYRROLIDINE DERIVATIVE OR SALT THEREOF
    申请人:Astellas Pharma Inc.
    公开号:EP1882684A1
    公开(公告)日:2008-01-30
    [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).
    [问题]提供一种可用于治疗钙传感受体(CaSR)相关疾病,特别是甲状旁腺机能亢进症的化合物。 [解决方法] 研究发现,新型吡咯烷衍生物(其特征在于具有被芳基烷基或类似基团取代的氨甲基)或其盐具有优异的 CaSR 激动调节活性,同时还具有优异的选择性和 CYP2D6 抑制活性,但有可能引起药物相互作用。基于以上所述,这些新型吡咯烷衍生物可作为治疗剂用于治疗与 CaSR 有关的疾病(甲状旁腺机能亢进症、肾性骨营养不良症、高钙血症等)。
  • Aminomercuration-Demercuration of Divinyl Sulfone: Synthesis of 4-Aryltetrahydro-1,4-thiazine 1,1-Dioxides
    作者:J. Barluenga、C. Jiménez、C. Nájera、M. Yus
    DOI:10.1055/s-1982-29820
    日期:——
查看更多

同类化合物

苯西酮 苯甲酸,4-(4-硫代吗啉基)- 硫代吗啉酮 硫代吗啉盐酸盐 硫代吗啉-4-醇1,1-二氧化物 硫代吗啉-4-甲酰氯-1,1-二氧化物 硫代吗啉-3-基甲醇 硫代吗啉-1-鎓-1-醇 硫代吗啉-1,1-二氧化物 硫代吗啉,4-[4-[[2-(2,4-二氯苯基)-2-(1H-咪唑-1-基甲基)-1,3-二噁戊环-4-基]甲氧基]苯基]-,1-氧化,顺-(9CI) 硫代吗啉,3-乙基-2-甲基- 硫代吗啉 1,1-二氧化物盐酸盐 硫代吗啉 甲基2-乙氧基-6H-1,3-噻嗪-5-羧酸酯 甲基2-(甲基氨基)-4-氧代-5,6-二氢-4H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-苄基-2-(苄基亚氨基)-4-氧代-1,3-噻嗪烷-6-羧酸酯 甲基(2Z)-3-异丙基-2-(异丙基亚胺)-4-氧代-1,3-噻嗪烷-6-羧酸酯 巯基吗啉-4-甲酸叔丁酯 四氢-3-甲基-2-苯基-4H-1,3-噻嗪-4-酮1,1-二氧化物 四氢-1,4-噻嗪-3,5-二酮 二苯甲基{5-[(4,6-二脱氧六吡喃糖基)氧代]-2,4,6-三羟基环己烷-1,3-二基}二(甲基氨基甲酸酯) N-甲基四氢-1,2-噻嗪S,S-二氧化物 N-甲基-4-硫代吗啉甲酰胺 N-环己基-5,6-二氢-4H-1,3-噻嗪-2-胺 N-亚硝基硫代吗啉 N-丁基-5,6-二氢-4H-1,3-噻嗪-2-胺 N-Boc-1,4-噻嗪S,S-二氧化物 N-(3-氨基丙基)-硫代吗啉 N-(2-羟基丙基)硫代吗啉 N-(2-羟乙基)吗啉 AMT盐酸盐 6-苄基-2-甲基噻嗪1,1-二氧化物 6-羟基-5,6-二甲基-1,3-噻吖己环-2-硫酮 6-甲基-4-苯基硫代吗啉-3-酮 6-甲基-2-苯基-5,6-二氢-4H-1,3-噻嗪 6-甲基-1,3-噻嗪-2-硫酮 6-异丙基-3-硫代吗啉酮 6-丙基-硫代吗啉-3-酮 6-(丁氧基甲基)-4-苯基硫代吗啉-3-酮 6,6-二甲基-1,4-噻嗪-2,5-二甲酸 5H-[1,3]噻唑并[5,4-h][1,4]苯并噻嗪 5-甲基-6-(吡啶-3-基)硫代吗啉-3-酮盐酸(1:1) 5-溴-1,3-噻嗪-2-硫酮 5-乙基-6-苯基-1,3-噻嗪烷-2,4-二酮 5,6-二氢-[1,3]噻唑并[2,3-c][1,4]噻嗪-8-羧酸乙酯 5,6-二氢-6-甲基-4H-1,3-噻嗪-2-胺 5,6-二氢-4H-1,4-噻嗪-2-羧酸乙酯 5,6-二氢-4H-1,3-噻嗪-2-羧酸甲酯 5,6-二氢-4H-1,3-噻嗪-2-基胺氢溴酸盐 5,6-二氢-4,4-二甲基-2-苯基-4H-1,3-噻嗪